The involvement of dityrosine crosslinking in synuclein assembly and deposition in Lewy Bodies in Parkinson's disease
Scientific Reports; http://doi.org/10.1038/srep39171.
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function..
EXP Neurol.; doi: 10.1016/j.expneurol.2016.09.003..
Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease..
Journal of Neuroimmune Pharmocology; doi: 10.1007/s11481-016-9713-6..
5-HT2A Receptor Binding in the Frontal Cortex of Parkinson’s Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study
Parkinson’s Disease; http://dx.doi.org/10.1155/2016/3682936.
Cerebrospinal fluid biomarkers and clinical features in leucine‐rich repeat kinase 2 (LRRK2) mutation carriers..
Mov Disord.; doi: 10.1002/mds.26591..
Protein Kinase Cδ Upregulation in Microglia Drives Neuroinflammatory Responses and Dopaminergic Neurodegeneration in Experimental Models of Parkinson's Disease.
NCBI; doi: 10.1016/j.nbd.2016.04.008.
Sensitive analysis of α-synuclein by nonlinear laser wave mixing coupled with capillary electrophoresis
Anal Biochem.; DOI: 10.1016/j.ab.2016.01.010.
Structure–activity relationships of radioiodinated diphenyl derivatives with different conjugated double bonds as ligands for α-synuclein aggregates
RSC Advances; DOI: 10.1039/C6RA02710E.
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.
ACS Publications; DOI: 10.1021/acs.jmedchem.5b01376.
Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
Journal of Neuroinflammation; DOI: 10.1186/s12974-016-0606-7.